Liquidia (LQDA) Competitors $16.66 -0.36 (-2.12%) Closing price 04:00 PM EasternExtended Trading$17.20 +0.54 (+3.24%) As of 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, PRCT, LIVN, and ENOVShould you be buying Liquidia stock or one of its competitors? The main competitors of Liquidia include Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Liquidia vs. Inari Medical Inspire Medical Systems iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista PROCEPT BioRobotics LivaNova Enovis Inari Medical (NASDAQ:NARI) and Liquidia (NASDAQ:LQDA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk. Which has stronger earnings & valuation, NARI or LQDA? Inari Medical has higher revenue and earnings than Liquidia. Inari Medical is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInari Medical$493.63M9.48-$1.64M-$1.35-59.24Liquidia$14.14M100.69-$78.50M-$1.58-10.54 Does the MarketBeat Community believe in NARI or LQDA? Liquidia received 147 more outperform votes than Inari Medical when rated by MarketBeat users. Likewise, 69.16% of users gave Liquidia an outperform vote while only 57.89% of users gave Inari Medical an outperform vote. CompanyUnderperformOutperformInari MedicalOutperform Votes6657.89% Underperform Votes4842.11% LiquidiaOutperform Votes21369.16% Underperform Votes9530.84% Does the media prefer NARI or LQDA? In the previous week, Liquidia had 18 more articles in the media than Inari Medical. MarketBeat recorded 18 mentions for Liquidia and 0 mentions for Inari Medical. Inari Medical's average media sentiment score of 0.84 beat Liquidia's score of 0.74 indicating that Inari Medical is being referred to more favorably in the media. Company Overall Sentiment Inari Medical Positive Liquidia Positive Do insiders and institutionals have more ownership in NARI or LQDA? 91.0% of Inari Medical shares are held by institutional investors. Comparatively, 64.5% of Liquidia shares are held by institutional investors. 10.6% of Inari Medical shares are held by company insiders. Comparatively, 26.5% of Liquidia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is NARI or LQDA more profitable? Inari Medical has a net margin of -13.68% compared to Liquidia's net margin of -765.38%. Inari Medical's return on equity of -10.09% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Inari Medical-13.68% -10.09% -6.60% Liquidia -765.38%-163.21%-67.14% Do analysts recommend NARI or LQDA? Inari Medical presently has a consensus price target of $69.22, indicating a potential downside of 13.44%. Liquidia has a consensus price target of $25.56, indicating a potential upside of 53.39%. Given Liquidia's stronger consensus rating and higher possible upside, analysts clearly believe Liquidia is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14Liquidia 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more risk & volatility, NARI or LQDA? Inari Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Liquidia has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. SummaryLiquidia beats Inari Medical on 10 of the 19 factors compared between the two stocks. Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidiaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.42B$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-10.228.9226.8419.71Price / Sales100.69250.96391.39116.98Price / CashN/A65.8538.2534.62Price / Book22.826.466.794.50Net Income-$78.50M$143.98M$3.23B$248.18M7 Day Performance-10.67%3.04%4.07%1.14%1 Month Performance25.36%7.44%12.52%15.18%1 Year Performance25.74%-2.46%16.83%6.55% Liquidia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia3.3422 of 5 stars$16.66-2.1%$25.56+53.4%+27.5%$1.42B$14.14M-10.2250News CoverageAnalyst DowngradeGap UpNARIInari Medical0.5635 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageINSPInspire Medical Systems4.6866 of 5 stars$156.54+3.5%$211.91+35.4%-3.4%$4.62B$840.11M90.49760Positive NewsGap UpIRTCiRhythm Technologies1.2948 of 5 stars$137.80+0.1%$128.55-6.7%+52.5%$4.40B$618.59M-37.861,790Positive NewsBLCOBausch + Lomb4.2513 of 5 stars$11.91+5.6%$15.50+30.2%-19.2%$4.21B$4.83B-13.0812,500TMDXTransMedics Group1.4465 of 5 stars$118.73+6.5%$126.70+6.7%-10.0%$4.02B$488.23M126.31210Positive NewsSLNOSoleno Therapeutics4.8538 of 5 stars$76.70-0.1%$106.78+39.2%+59.6%$3.87BN/A-23.1030News CoveragePositive NewsNVSTEnvista4.2021 of 5 stars$18.56+5.5%$20.08+8.2%-2.7%$3.15B$2.50B-2.8612,700Positive NewsGap UpPRCTPROCEPT BioRobotics2.9388 of 5 stars$54.44+2.5%$90.00+65.3%-13.9%$3.01B$249.12M-27.92430Positive NewsLIVNLivaNova3.8036 of 5 stars$45.23+2.7%$59.17+30.8%-26.8%$2.47B$1.28B107.692,900Positive NewsAnalyst UpgradeHigh Trading VolumeENOVEnovis3.2146 of 5 stars$36.67+11.0%$55.00+50.0%-32.6%$2.09B$2.15B-16.746,800High Trading Volume Related Companies and Tools Related Companies Inari Medical Competitors Inspire Medical Systems Competitors iRhythm Technologies Competitors Bausch + Lomb Competitors TransMedics Group Competitors Soleno Therapeutics Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LQDA Stock Free LQDA Stock Alerts